Abbott Laboratories
DE ˙ XTRA ˙ US0028241000
75,22 € ↑1,20 (1,62%)
2026-06-03
AKTIENPREIS
SecurityDE:ABL / Abbott Laboratories
InstitutionDynasty Wealth Management, Llc
Latest Disclosed Ownership14,039 shares
Latest Disclosed Value $ 1,441,348
Dynasty Wealth Management, Llc reports 53.22% decrease in ownership of ABL / Abbott Laboratories

On May 14, 2026 - Dynasty Wealth Management, Llc filed a 13F-HR form disclosing ownership of 14,039 shares of Abbott Laboratories (DE:ABL) valued at $1,246,944 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 30,012 shares of Abbott Laboratories. This represents a change in shares of -53.22% during the quarter. The current value of the position is $1,056,014 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F ABBOTT LABS COM 002824100 14,039 -15,973 -53.22 1,441 -61.68 0.0126
2026-02-10 2025-12-31 13F ABBOTT LABS COM 002824100 30,012 737 2.52 3,760 -4.11 0.0369
2025-10-29 2025-09-30 13F ABBOTT LABS COM 002824100 29,275 -3,954 -11.90 3,921 -13.23 0.0523
2025-08-05 2025-06-30 13F ABBOTT LABS COM 002824100 33,229 -1,306 -3.78 4,519 -1.35 0.0770
2025-05-02 2025-03-31 13F ABBOTT LABS COM 002824100 34,535 -189 -0.54 4,581 16.65 0.0763
2025-02-05 2024-12-31 13F ABBOTT LABS COM 002824100 34,724 -190 -0.54 3,928 -1.33 0.0678
2024-11-12 2024-09-30 13F ABBOTT LABS COM 002824100 34,914 -3,078 -8.10 3,981 0.84 0.1203
2024-08-12 2024-06-30 13F ABBOTT LABS COM 002824100 37,992 3,286 9.47 3,948 0.08 0.1164
2024-05-16 2024-03-31 13F ABBOTT LABS COM 002824100 34,706 34,706 3,945 0.1258
2019-02-12 2018-12-31 13F ABBOTT LABS COM COM 002824100 0 -4,768 -100.00 0 -100.00
2018-11-09 2018-09-30 13F ABBOTT LABS COM COM 002824100 4,768 4,768 350 0.4505
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.